Introduction
The compound data sets reported in our original article 1 and the new data sets presented herein have resulted from research in the chemoinformatics and medicinal chemistry area and have mostly been generated from public domain repositories of compound structures and activity data. In addition, software tools made publicly available have also been developed in our laboratory 1 . Data sets reported in the scientific literature in the context of computational method development and evaluation are often not publicly available, which limits the reproducibility of computational investigations and comparisons of different computational methods. We believe that it is important to provide such data to the scientific community to further improve the transparency and credibility of computational studies and support method development. In addition to the data sets designed for the development and evaluation of computational methods, we also make available data sets that were generated as a resource and knowledge base for medicinal chemistry applications. Our data sets and tools are provided via the ZENODO platform (https://zenodo.org/) to ensure easy and stable access.
Materials and methods
The data sets reported herein were predominantly generated from ChEMBL 2,3 , BindingDB 4 and PubChem 5 (a few exceptions are specified in the original data article 1 ). Compound structures are represented as SMILES 6 strings or SD files 7 . Activity information and other (data set-dependent) annotations are provided in the individual data files. For software tools (written in different languages), the source code is also made available. Table 1 provides the updated list and classification of all freely available data sets and programs. Entries were organized according to the following scientific subject areas: data sets for structure-activity relationship (SAR) and structure-selectivity relationship (SSR) analysis, SAR visualization (SAR_VZ), and virtual screening via similarity searching or machine learning (VS_ML). In addition, the programs are provided separately (PROG). Data sets and programs are contained in separate ZENODO deposition sets with a unique reference. Three matched molecular pair (MMP)-based data sets also included in our update have recently been reported and described in detail 8 . Entries 1-30 in Table 1 represent the data sets and programs that we initially provided via our website 1 and entries 31-43 represent new data sets. In the following, the new data sets are described:
Data description
Entry 31 50 compound activity classes (AC) are prioritized for the evaluation of scaffold hopping potential in ligand-based virtual screening 38 . These AC contain the largest proportion of scaffold pairs with largest chemical inter-scaffold distances 38 that can be derived from current bioactive compounds and hence present challenging test cases for scaffold hopping analysis.
Entry 32
596 SAR transfer series with regular potency progression (SAR-TS-RP) are extracted from 61 AC 39 . Each SAR-TS-RP represents two compound series with different core structures and pairwise corresponding substitutions that yield comparable potency progression against a given target. These series provide a knowledge base for the analysis and prediction of SAR transfer events.
Entry 33
Four sets of molecular scaffolds (with each scaffold representing more than ten compounds) are provided that are active against a single target (ST), multiple targets from the same family (SF), or multiple targets from different families (MF) 40 . Data sets are separately assembled for different types of potency measurements (i.e., K i and IC 50 values) and provide a resource of scaffolds representing compounds with varying degrees of target promiscuity.
Entry 34
Two multi-target compound data sets consist of confirmed screening hits 41 . Each set contains compounds with single-, dual-, and triple-target activity, or no activity. These data provide test cases for machine learning or other approaches to differentiate between compounds with overlapping yet distinct activity profiles.
Entry 35
Four multi-target compound data sets are provided 42 . Each set contains compounds tested in three different assays. Compounds are organized into eight different subsets according to their activity profiles, i.e., single-, dual-, and triple-target activity, or no activity. In addition, three multi-mechanism compound sets are designed 42 . In the latter case, compounds are organized into four subsets according to their mechanism-of-action. These data sets also represent test cases for machine learning to distinguish compounds with different activity profiles or mechanisms.
Entry 36 2337 non-redundant compound series matrices (CSMs) are generated covering compounds active against a wide spectrum of targets 43 . Each matrix contains at least two analogous matching molecular series (MMS) with structurally related yet distinct cores. A matrix consists of known active compounds and structurally related virtual compounds and hence provides suggestions for compound design.
Entry 37 128 target-based data sets are assembled that consist of at least 100 compounds with precisely specified equilibrium constants (K i values) below 1 µM for human targets 44 . These high-confidence activity data sets provide a sound basis for SAR exploration. . Accordingly, these scaffolds have been termed drug-unique scaffolds.
Entry 40 92,734 MMPs are generated from 435 AC on a basis of retrosynthetic rules 47 . These MMPs consider chemical reaction information and should be useful for practical medicinal chemistry applications. [18] 2009 VS_ML_5 20 AC from the literature and 15 AC from the Molecular Drug Data Report 12 [19] 2010 VS_ML_6 8 AC 13 [20] 2010 PROG_3 Program to generate target selectivity patterns of scaffolds 14 [21] 2010 PROG_4 Multi-target CAGs (see also entry 10) with a sample set containing 33 kinase inhibitors 15 [22] 2010 PROG_5 SARANEA 16 [23] 2010 PROG_6 3D activity landscape program with a sample set containing 248 cathepsin S inhibitors 17 [24] 2010 SAR_1 2 sets of MMPs from BindingDB and ChEMBL 18 [25] 2010 PROG_7 Similarity-potency tree (SPT) program with a sample set containing 874 factor Xa inhibitors 19 [26] 2010 VS_ML_7 17 target-directed compound sets; each set contains a minimum of 10 distinct scaffolds and each scaffold represents 5 compounds 20 [27] 2011 SAR_VZ 10,489 malaria screening hits 21 [28] 2011 SAR_2 458 target-based sets with scaffolds and scaffold hierarchies 22 [29] 2011 SAR_VZ 4 sets of compounds active against 3 or 4 targets 23 [30] 2011 SAR_VZ 881 factor Xa inhibitors 24 [31] 2011 VS_ML_8 50 AC prioritized for similarity searching 25 [32] 2011 VS_ML_9 25 data sets from successful ligand-based virtual screening applications 26 [33] Data entries are organized according to scientific subject areas: structure-activity relationship (SAR) and structure-selectivity relationship (SSR) analysis, SAR visualization (SAR_VZ), virtual screening via similarity searching or machine learning (VS_ML), and programs (PROG). References in the Entry column provide the original publication introducing the program and/or data set. Program entries are described in more detail in 
Summary
Herein we have provided an updated release of data sets and programs for chemoinformatics and medicinal chemistry that we make freely available. In total, 13 new data sets are introduced.
Transferring all data entries in an organized form to the ZENODO platform makes them easily accessible. We hope that our current release might be of interest and helpful to many investigators in academia and the pharmaceutical industry.
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